(VETO) Vetoquinol - Performance -20.5% in 12m
VETO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-20.40%
#81 in Peer-Group
Rel. Strength
23.35%
#5684 in Stock-Universe
Total Return 12m
-20.54%
#127 in Peer-Group
Total Return 5y
13.65%
#54 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 14.5 |
| P/E Forward | - |
| High / Low | EUR |
|---|---|
| 52 Week High | 101.39 EUR |
| 52 Week Low | 63.05 EUR |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 89.57 |
| Buy/Sell Signal +-5 | 0.37 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VETO (-20.5%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
2.4% | 125% | 327% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.69% | 17.7% | 78.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
4.34% | -14.2% | 404% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.15% | 2.99% | 49.2% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-7.83% | 4.46% | 46.4% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-6.3% | -5% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-2.85% | -8.53% | 45.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-1.19% | -10.7% | 41.1% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: VETO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for VETO
| Total Return (including Dividends) | VETO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 1.06% | 2.04% | 4.55% |
| 3 Months | -3.11% | -7.24% | 10.78% |
| 12 Months | -20.54% | -5.41% | 14.71% |
| 5 Years | 13.65% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | VETO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -33.4% | 34.5% | 79.2% |
| 3 Months | -61% | -46.5% | 92.9% |
| 12 Months | -81.5% | -71.8% | 44.2% |
| 5 Years | -26.3% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th52.58 | -0.96% | -3.34% |
| 3 Month | %th41.75 | 4.45% | -12.54% |
| 12 Month | %th35.57 | -15.99% | -30.73% |
| 5 Years | %th71.65 | -20.85% | -46.52% |
FAQs
Does Vetoquinol (VETO) outperform the market?
No,
over the last 12 months VETO made -20.54%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months VETO made -3.11%, while XLV made -7.24%.
Performance Comparison VETO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VETO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.7% | -3.5% | -5.8% | -35% |
| US NASDAQ 100 | QQQ | -0.1% | -4.5% | -7.9% | -36% |
| German DAX 40 | DAX | 0.8% | 1.1% | -18.7% | -51% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1% | -3.1% | -3.8% | -38% |
| Hongkong Hang Seng | HSI | 1.1% | -4.7% | -21.5% | -56% |
| India NIFTY 50 | INDA | 1.1% | -1% | -5.5% | -20% |
| Brasil Bovespa | EWZ | -0.7% | -6.7% | -30.3% | -34% |
VETO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.8% | -5.7% | -12.5% | -49% |
| Consumer Discretionary | XLY | 2.3% | -0.6% | 2.9% | -40% |
| Consumer Staples | XLP | 4.2% | 2.7% | -4% | -30% |
| Energy | XLE | 5.1% | -2.5% | -0.3% | -17% |
| Financial | XLF | 0.6% | -2% | -8.9% | -50% |
| Health Care | XLV | 1.6% | -1% | 1.4% | -15% |
| Industrial | XLI | 1.1% | -2.7% | -12.4% | -45% |
| Materials | XLB | 2.6% | -0.6% | -5.1% | -24% |
| Real Estate | XLRE | 5.2% | 1.1% | -3.2% | -33% |
| Technology | XLK | -0.6% | -7.8% | -9% | -32% |
| Utilities | XLU | 3.1% | 1% | -9.2% | -45% |
| Aerospace & Defense | XAR | -1.3% | -8.8% | -27.2% | -73% |
| Biotech | XBI | 2.8% | -1% | 8.2% | -10% |
| Homebuilder | XHB | 2.4% | -5% | 5.5% | -21% |
| Retail | XRT | 3.8% | -0.4% | 2.9% | -27% |
VETO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 8% | -4.06% | 3.48% | -10% |
| Natural Gas | UNG | 12.9% | 10.5% | 9.4% | -13% |
| Gold | GLD | 5.6% | 3.3% | -25.7% | -62% |
| Silver | SLV | 4.1% | -2.8% | -24.4% | -43% |
| Copper | CPER | 0.4% | -3.1% | -25.5% | -36% |
VETO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.9% | -2.6% | -2.6% | -23% |
| iShares High Yield Corp. Bond | HYG | 2.8% | -0.8% | -4.8% | -31% |